why choose us

First received: October 13, 2023

Clinical Trial: A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or

Study Type: INTERVENTIONAL


Official Title: A Parallel-group Treatment, Proof-of-concept Phase 2, Multicenter, Double-blind, Randomized Two-arm Clinical Trial to Investigate the Efficacy and Safety of Subcutaneous NT 201 Injections Compared Wit

Brief Summary: In this clinical trial, participants with nerve pain after shingles or nerve injury will receive injections with NT 201 or placebo.The purpose is to measure the decrease of nerve pain with NT 201 compared to placebo.Trial details include:Trial duration: 22-23 weeks;Treatment duration: 1 injection visit with a 20-week follow-up period;Visit frequency: 2 remote visits by phone/video call (1 week and 12 weeks after the injection); 2 on-site visits (6 weeks and 20 weeks after the injection).

Read more